Platelet-expressed immune checkpoint regulator GITRL in breast cancer.

Cancer Immunol Immunother · 2021 · PMC8360840 · PMID 33538861

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

slightly failed to reach statistical significanceno p-value reported

With regard to its cognate receptor, CD19 + B cells of breast cancer patients displayed a trend towards lower GITR expression, whereas NK cells showed higher expression levels compared to HD, an observation which in T cells slightly failed to reach statistical significance.

also in 15 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.